These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17482894)

  • 1. Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
    Schambach A; Baum C
    DNA Repair (Amst); 2007 Aug; 6(8):1187-96. PubMed ID: 17482894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of a P140K mutant O6-methylguanine-DNA-methyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow.
    Kramer BA; Lemckert FA; Alexander IE; Gunning PW; McCowage GB
    J Gene Med; 2006 Sep; 8(9):1071-85. PubMed ID: 16927363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O6-methylguanine-DNA-methyltransferase (MGMT) gene therapy targeting haematopoietic stem cells: studies addressing safety issues.
    Sorg UR; Kleff V; Fanaei S; Schumann A; Moellmann M; Opalka B; Thomale J; Moritz T
    DNA Repair (Amst); 2007 Aug; 6(8):1197-209. PubMed ID: 17499560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells.
    Ragg S; Xu-Welliver M; Bailey J; D'Souza M; Cooper R; Chandra S; Seshadri R; Pegg AE; Williams DA
    Cancer Res; 2000 Sep; 60(18):5187-95. PubMed ID: 11016647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal relationship between O6-methylguanine-DNA methyltransferase P140K expression level and chemoprotection of hematopoietic stem cells.
    Milsom MD; Jerabek-Willemsen M; Harris CE; Schambach A; Broun E; Bailey J; Jansen M; Schleimer D; Nattamai K; Wilhelm J; Watson A; Geiger H; Margison GP; Moritz T; Baum C; Thomale J; Williams DA
    Cancer Res; 2008 Aug; 68(15):6171-80. PubMed ID: 18676840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells.
    Jansen M; Sorg UR; Ragg S; Flasshove M; Seeber S; Williams DA; Moritz T
    Cancer Gene Ther; 2002 Sep; 9(9):737-46. PubMed ID: 12189523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral-mediated expression of the P140A, but not P140A/G156A, mutant form of O6-methylguanine DNA methyltransferase protects hematopoietic cells against O6-benzylguanine sensitization to chloroethylnitrosourea treatment.
    Maze R; Kurpad C; Pegg AE; Erickson LC; Williams DA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1467-74. PubMed ID: 10454526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
    Schambach A; Bohne J; Chandra S; Will E; Margison GP; Williams DA; Baum C
    Mol Ther; 2006 Feb; 13(2):391-400. PubMed ID: 16226060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotection.
    Milsom MD; Williams DA
    DNA Repair (Amst); 2007 Aug; 6(8):1210-21. PubMed ID: 17482893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug selection of mutant methylguanine methyltransferase from different oncoretroviral backbones results in multilineage hematopoietic transgene expression in primary and secondary recipients.
    Davis BM; Reese JS; Lingas K; Gerson SL
    J Hematother Stem Cell Res; 2003 Aug; 12(4):375-87. PubMed ID: 12965075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal inventory screens uncover monoclonality following serial transplantation of MGMT P140K-transduced stem cells and dose-intense chemotherapy.
    Giordano FA; Sorg UR; Appelt JU; Lachmann N; Bleier S; Roeder I; Kleff V; Flasshove M; Zeller WJ; Allgayer H; von Kalle C; Fruehauf S; Moritz T; Laufs S
    Hum Gene Ther; 2011 Jun; 22(6):697-710. PubMed ID: 21319998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.
    Kaina B; Christmann M; Naumann S; Roos WP
    DNA Repair (Amst); 2007 Aug; 6(8):1079-99. PubMed ID: 17485253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F2A sequence linking MGMT(P140K) and MDR1 in a bicistronic lentiviral vector enables efficient chemoprotection of haematopoietic stem cells.
    Maier P; Heckmann D; Spier I; Laufs S; Zucknick M; Allgayer H; Fruehauf S; Zeller WJ; Wenz F
    Cancer Gene Ther; 2012 Nov; 19(11):802-10. PubMed ID: 23037811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O(6)-methylguanine-DNA methyltransferase(P140K).
    Maier P; Spier I; Laufs S; Veldwijk MR; Fruehauf S; Wenz F; Zeller WJ
    Gene Ther; 2010 Mar; 17(3):389-99. PubMed ID: 19865182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones.
    Jansen M; Bardenheuer W; Sorg UR; Seeber S; Flasshove M; Moritz T
    Eur J Haematol; 2001 Jul; 67(1):2-13. PubMed ID: 11553261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral MGMT(P140K)-mediated in vivo selection employing a ubiquitous chromatin opening element (A2UCOE) linked to a cellular promoter.
    Phaltane R; Lachmann N; Brennig S; Ackermann M; Modlich U; Moritz T
    Biomaterials; 2014 Aug; 35(25):7204-13. PubMed ID: 24875758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual agent chemoprotection by retroviral co-expression of either MDR1 or MRP1 with the P140K mutant of O6-methylguanine-DNA-methyl transferase.
    Southgate TD; Garside E; Margison GP; Fairbairn LJ
    J Gene Med; 2006 Aug; 8(8):972-9. PubMed ID: 16733832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency and safety of O⁶-methylguanine DNA methyltransferase (MGMT(P140K))-mediated in vivo selection in a humanized mouse model.
    Phaltane R; Haemmerle R; Rothe M; Modlich U; Moritz T
    Hum Gene Ther; 2014 Feb; 25(2):144-55. PubMed ID: 24218991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human variants of O6-alkylguanine-DNA alkyltransferase.
    Pegg AE; Fang Q; Loktionova NA
    DNA Repair (Amst); 2007 Aug; 6(8):1071-8. PubMed ID: 17482892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus.
    Schambach A; Schiedlmeier B; Kühlcke K; Verstegen M; Margison GP; Li Z; Kamino K; Bohne J; Alexandrov A; Hermann FG; von Laer D; Baum C
    Gene Ther; 2006 Jul; 13(13):1037-47. PubMed ID: 16541120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.